Shanghai Kehua Bio-Engineering Co.,Ltd
SZSE:002022.SZ
9.21 (CNY) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Shanghai Kehua Bio-Engineering Co.,Ltd |
Symbool | 002022.SZ |
Munteenheid | CNY |
Prijs | 8.46 |
Beurswaarde | 4,350,960,945 |
Dividendpercentage | 0% |
52-weken bereik | 8.17 - 14.42 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Ming Li |
Website | https://www.skhb.com |
An error occurred while fetching data.
Over Shanghai Kehua Bio-Engineering Co.,Ltd
Shanghai Kehua Bio-Engineering Co.,Ltd researches and develops, produces, and sells in vitro diagnostic products in China. The company offers HBV, hepatitis B, HCV antibody, alpha fetoprotein quantitative, and fecal occult blood test kits; carcino-embryonic antigen quantitative determination kits; test kits for antibody to treponema pallidum and human immunodeficiency virus, and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)